New Childhood Cancer Advocacy Group States Seven Key Aims

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 6
Volume 11
Issue 6

ALEXANDRIA, Virginia-More than 20 national advocacy groups, professional medical societies, and scientific organizations have joined to form the Alliance for Childhood Cancer to support quality cancer care for children and adolescents.

ALEXANDRIA, Virginia—More than 20 national advocacy groups, professional medical societies, and scientific organizations have joined to form the Alliance for Childhood Cancer to support quality cancer care for children and adolescents.

Seven core principles will guide the group’s efforts: (1) Early access to pediatric oncology specialists for evaluation, diagnosis, and treatment; (2) treatment by a multidisciplinary team of specialists; (3) insurance coverage for clinical trials; (4) access to the full continuum of care, including insurance coverage for these services; (5) portability of insurance coverage; (6) long-term follow-up care; and (7) funding to support research to improve the care and quality of life of children and adolescents, and the training of skilled pediatric cancer specialists.

Recent Videos
A new partnership agreement involving AI use may help spread radiotherapeutic standards from academic centers to more patients in community-based practices.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications.
The 3 most likely directions of radiotherapy advancements come from new technology, combinations with immunotherapy, and the incorporation of particle therapy.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
4 experts in this video
4 experts in this video